Budapest, Hungary

Ágnes Kunsztné Kárász


Average Co-Inventor Count = 17.5

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ágnes Kunsztné Kárász

Introduction

Ágnes Kunsztné Kárász is a notable inventor based in Budapest, Hungary. He has significantly contributed to the field of chemistry through his innovative processes and has been recognized for his work with a total of two patents. His inventions focus on the synthesis of chemical compounds that are essential in pharmaceutical applications.

Latest Patents

Ágnes Kunsztné Kárász's latest patents include a process for the preparation of 1,3-diaza-spiro (4.4) non-1-en-4-one derivatives and 1-cyano-1-acylaminocyclopentane intermediates. These patents detail methods for synthesizing compounds characterized by specific chemical structures, wherein R can represent various groups such as hydrogen, alkyl, aralkyl, or phenyl. The processes involve reacting compounds with halogens or anhydrides, followed by oxidation in a mildly alkaline medium. These inventions are particularly relevant in the creation of intermediates used in the synthesis of angiotensin II antagonists, which are important for managing various cardiovascular conditions.

Career Highlights

Ágnes Kunsztné Kárász is affiliated with Sanofi-Synthelabo, where he applies his expertise in research and development. His work has contributed to advancements in pharmaceutical chemistry, demonstrating not only his inventiveness but also his dedication to improving health outcomes through innovative solutions.

Collaborations

Throughout his career, Kárász has collaborated with esteemed colleagues like Attila Kis-Tamás and Csaba Huszár. These collaborations foster a creative environment where new ideas flourish, leading to successful innovations in the field.

Conclusion

Ágnes Kunsztné Kárász exemplifies the spirit of innovation in the scientific community. His patents not only showcase his talent as an inventor but also underline the importance of collaboration within research institutions. As he continues his work, Kárász remains a significant figure in the development of new pharmaceutical compounds, contributing to advancements in healthcare and medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…